Masimo Corp. announced that it won a $634 million verdict against Apple Inc. last Friday.
A California federal jury sided with the Irvine-based medical device maker, finding that Apple’s watches infringed on Masimo’s patented pulse oximetry technology.
“We are pleased by this outcome, and appreciate the time and attention given to our case by the court and the jury,” Masimo said in a statement.
Apple plans to appeal the decision, according to several reports.
Shares in Masimo today were down less than 1% to $150.17 apiece and an $8 billion market cap (Nasdaq: MASI).
